Sir,

Recently, a new coronavirus was identified as the cause of the severe acute respiratory syndrome (SARS).[1](#DKH002C1) In the absence of a specific treatment for SARS, the possibility that vitamin C may show non-specific effects on severe viral respiratory tract infections should be considered. There are numerous reports indicating that vitamin C may affect the immune system,[2](#DKH002C2)^,^[3](#DKH002C3) for example the function of phagocytes, transformation of T lymphocytes and production of interferon. In particular, vitamin C increased the resistance of chick embryo tracheal organ cultures to infection caused by an avian coronavirus.[4](#DKH002C4) Studies in animals found that vitamin C modifies susceptibility to various bacterial and viral infections,[3](#DKH002C3) for example protecting broiler chicks against an avian coronavirus.[5](#DKH002C5) Placebo-controlled trials have shown quite consistently that the duration and severity of common cold episodes are reduced in the vitamin C groups,[3](#DKH002C3) indicating that viral respiratory infections in humans are affected by vitamin C levels. There is also evidence indicating that vitamin C may affect pneumonia.[3](#DKH002C3) In particular, three controlled trials with human subjects reported a significantly lower incidence of pneumonia in vitamin C-supplemented groups,[6](#DKH002C6) suggesting that vitamin C may affect susceptibility to lower respiratory tract infections under certain conditions. The possibility that vitamin C affects severe viral respiratory tract infections would seem to warrant further study, especially in light of the recent SARS epidemic.
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